Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Kojima · SciRah

Researcher profile · Semantic Scholar

Y. Kojima

Share profile

Y. Kojima — researcher profile on SciRah

h-index: 26
Works: 96
Citations: 2,433

Most-cited papers

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: The FUGA-BT (JCOG1113) Randomized Phase III Clinical Trial.
C. Morizane, T. Okusaka, J. Mizusawa, H. Katayama +33 more
2019Annals of Oncology280 citations Open access
Semantic Scholar
Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study.
N. Nagata, Suguru Nishijima, Y. Kojima, Yuya Hisada +24 more
2022Gastroenterology178 citations Open access
Semantic Scholar
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
M. Ikeda, S. Shimizu, Tosiya Sato, M. Morimoto +14 more
2016Annals of Oncology167 citations Open access
Semantic Scholar
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
S. Iwasa, C. Morizane, T. Okusaka, H. Ueno +8 more
2010Japanese Journal of Clinical Oncology156 citations Open access
Semantic Scholar
Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome.
N. Nagata, Suguru Nishijima, T. Miyoshi-Akiyama, Y. Kojima +14 more
2022Gastroenterology137 citations Open access
Semantic Scholar
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
T. Yokota, Ken Kato, Y. Hamamoto, Y. Tsubosa +16 more
2016British Journal of Cancer137 citations Open access
Semantic Scholar
Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort
Suguru Nishijima, N. Nagata, Yuya Kiguchi, Y. Kojima +10 more
2022Nature Communications114 citations Open access
Semantic Scholar
Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
Miho Kaida, Yuriko Morita-Hoshi, A. Soeda, T. Wakeda +9 more
2011Journal of immunotherapy105 citations
Semantic Scholar
Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
Satoshi Kobayashi, T. Terashima, S. Shiba, Y. Yoshida +16 more
2018Cancer Science75 citations Open access
Semantic Scholar
Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study
S. Shiba, H. Imaoka, K. Shioji, E. Suzuki +13 more
2018BMC Cancer63 citations Open access
Semantic Scholar
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies
M. Kobayakawa, Y. Kojima
2011OncoTargets and Therapy55 citations Open access
Semantic Scholar
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer
T. Yokota, Ken Kato, Y. Hamamoto, Y. Tsubosa +16 more
2019Annals of Surgical Oncology53 citations
Semantic Scholar
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
Y. Maruki, C. Morizane, Y. Arai, M. Ikeda +22 more
2020Journal of gastroenterology48 citations Open access
Semantic Scholar
Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.
Tsutomu Tanaka, M. Ikeda, T. Okusaka, H. Ueno +4 more
2008Japanese Journal of Clinical Oncology47 citations
Semantic Scholar
Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study.
N. Nagata, A. Kawazoe, S. Mishima, T. Wada +14 more
2016Radiology46 citations
Semantic Scholar
Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux
J. Akiyama, H. Hosaka, S. Kuribayashi, Shiori Moriyasu +12 more
2019Digestion44 citations
Semantic Scholar
Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately
Tsukasa Yoshida, S. Hijioka, W. Hosoda, M. Ueno +31 more
2019Annals of Surgical Oncology41 citations
Semantic Scholar
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma
H. Tsurumi, Toshiki Yamada, M. Sawada, S. Kasahara +10 more
2004Journal of Cancer Research and Clinical Oncology41 citations Open access
Semantic Scholar
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
M. Ikeda, T. Yamashita, S. Ogasawara, M. Kudo +12 more
2023Liver Cancer37 citations Open access
Semantic Scholar
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan
H. Kage, A. Shinozaki-Ushiku, Kazunaga Ishigaki, Yusuke Sato +27 more
2023Cancer Science35 citations Open access
Semantic Scholar
Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B‐cell lymphoma and its subtypes
Rumiko Watanuki-Miyauchi, Y. Kojima, H. Tsurumi, T. Hara +5 more
2005Pathology international (Print)34 citations
Semantic Scholar
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?
K. Hashimoto, H. Ueno, M. Ikeda, Y. Kojima +4 more
2009Oncology33 citations
Semantic Scholar
Fas and Fas ligand expression on germinal center type‐diffuse large B‐cell lymphoma is associated with the clinical outcome
Y. Kojima, H. Tsurumi, N. Goto, M. Shimizu +11 more
2006European Journal of Haematology33 citations Open access
Semantic Scholar
Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease
K. Sekine, N. Nagata, Kayo Sakamoto, T. Arai +15 more
2015Journal of Gastroenterology and Hepatology32 citations
Semantic Scholar
Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma
Hideaki Takahashi, M. Ikeda, S. Shiba, H. Imaoka +16 more
2020Pancreas31 citations Open access
Semantic Scholar
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases
E. Suzuki, J. Furuse, M. Ikeda, T. Okusaka +8 more
2010Oncology30 citations
Semantic Scholar
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial)
H. Okuyama, M. Ikeda, T. Okusaka, M. Furukawa +11 more
2020Neuroendocrinology26 citations Open access
Semantic Scholar
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
M. Ikeda, S. Shiina, K. Nakachi, S. Mitsunaga +11 more
2014Investigational new drugs26 citations Open access
Semantic Scholar
The Role of the Tumor Necrosis Factor Receptor in 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis in Mice
M. Nakai, Kaori Sudo, Yasuhiro Yamada, Y. Kojima +4 more
2005Digestive Diseases and Sciences26 citations
Semantic Scholar
Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups.
Hiroki Tanaka, S. Hijioka, W. Hosoda, M. Ueno +20 more
2020Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]25 citations Open access
Semantic Scholar
Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand–foot skin reactions in sorafenib-treated patients
Kosuke Saito, M. Ikeda, Y. Kojima, H. Hosoi +2 more
2018Cancer Chemotherapy and Pharmacology22 citations
Semantic Scholar
Diffuse Liver Metastasis of Small-Cell Lung Cancer Presenting as Acute Liver Failure and Diagnosed by Transjugular Liver Biopsy: A Rare Case in Whom Nodular Lesions Were Detected by Enhanced CT Examination
S. Mishima, Y. Nozaki, S. Mikami, Eri Kihira +20 more
2015Case Reports in Gastroenterology18 citations Open access
Semantic Scholar
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
Y. Sasaki, S. Iwasa, S. Okazaki, M. Goto +9 more
2018Gastric Cancer16 citations Open access
Semantic Scholar
Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
M. Ikeda, T. Okusaka, H. Ueno, C. Morizane +3 more
2008Japanese Journal of Clinical Oncology14 citations
Semantic Scholar
Hepatic Arterial Infusion Chemotherapy with Epirubicin in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
M. Ikeda, T. Okusaka, H. Ueno, C. Morizane +3 more
2007Oncology14 citations
Semantic Scholar
Diffuse Large B-Cell Lymphoma with Tumor Thrombosis in the Portal Vein
N. Kanemura, H. Tsurumi, Toshiki Yamada, Y. Kojima +2 more
2006International journal of hematology14 citations
Semantic Scholar
Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
M. Kijima, M. Saio, Guan-Feng Oyang, Tatsuhiko Suwa +8 more
2005International Journal of Oncology14 citations
Semantic Scholar
Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis.
Y. Yoshida, Satoshi Kobayashi, M. Ueno, C. Morizane +27 more
2022Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]11 citations
Semantic Scholar
Phase I/II study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results.
S. Mitsunaga, M. Ikeda, H. Ueno, K. Nakachi +8 more
201311 citations
Semantic Scholar
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer
Satoshi Kobayashi, Motoko Suzuki, M. Ueno, Y. Maruki +28 more
2022The Oncologist10 citations Open access
Semantic Scholar
FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study
K. Umemoto, Hideaki Takahashi, C. Morizane, I. Yamada +12 more
2021Cancer Chemotherapy and Pharmacology10 citations Open access
Semantic Scholar
In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
N. Ohe, M. Saio, M. Kijima, N. Tamakawa +8 more
2003International Journal of Oncology10 citations
Semantic Scholar
The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
I. Yamada, C. Morizane, T. Okusaka, J. Mizusawa +34 more
2022Scientific Reports9 citations Open access
Semantic Scholar
Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer
Satoshi Kobayashi, M. Ueno, K. Sugimori, C. Morizane +5 more
2017Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
A. Hagihara, M. Ikeda, H. Ueno, C. Morizane +13 more
2014Cancer Science9 citations Open access
Semantic Scholar
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
C. Morizane, T. Okusaka, H. Ueno, S. Kondo +9 more
2012Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites.
A. Soeda, Yuriko Morita-Hoshi, Miho Kaida, T. Wakeda +8 more
2010Japanese Journal of Clinical Oncology8 citations Open access
Semantic Scholar
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
M. Ikeda, T. Yamashita, S. Ogasawara, M. Kudo +12 more
2021Annals of Oncology7 citations Open access
Semantic Scholar
Hepatocellular carcinoma presenting with lung metastasis: Clinical characteristics and prognostic factors.
Y. Kojima, H. Ueno, T. Okusaka, C. Morizane +3 more
2009Journal of Clinical Oncology7 citations
Semantic Scholar
Refractory Chylothorax and Lymphedema Caused by Advanced Gastric Cancer
Naoko Nagano, Manabu Suzuki, K. Tamura, Sakurako Kobayashi +6 more
2019Internal medicine6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Morizane×24
Invite
C. Morizane — researcher profile on SciRah
M. Ikeda×24
Invite
M. Ikeda — researcher profile on SciRah
T. Okusaka×19
Invite
T. Okusaka — researcher profile on SciRah
J. Furuse×17
Invite
J. Furuse — researcher profile on SciRah

×13

Invite

M. Ueno — researcher profile on SciRah

Invite

H. Ueno — researcher profile on SciRah

Invite

S. Kondo — researcher profile on SciRah

Invite

S. Shimizu — researcher profile on SciRah

Invite

A. Hagihara — researcher profile on SciRah

Invite

N. Mizuno — researcher profile on SciRah

Invite

K. Shioji — researcher profile on SciRah

Invite

A. Asagi — researcher profile on SciRah